0000920465-17-000093.txt : 20171229
0000920465-17-000093.hdr.sgml : 20171229
20171229170756
ACCESSION NUMBER: 0000920465-17-000093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171227
FILED AS OF DATE: 20171229
DATE AS OF CHANGE: 20171229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARVER JENNIFER
CENTRAL INDEX KEY: 0001663163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 171282627
MAIL ADDRESS:
STREET 1: 725 NEWPORT STREET
CITY: DENVER
STATE: CO
ZIP: 80220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_151458526196808.xml
FORM 4
X0306
4
2017-12-27
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001663163
CARVER JENNIFER
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Operating Officer
Common Stock
2017-12-27
4
P
0
1000
33.215
A
4500
D
/s/ Ryan Murr, as attorney-in-fact for Jennifer A. Carver
2017-12-29